BioCryst share price logo

BioCryst

NASDAQ: BCRX

Mid Cap

$8.36

-0.45

(-5.05%)

Live

as on

BioCryst Stock Performance

as on September 11, 2026 at 12:35 am IST

  • Day's Low

    Day's High

    $8.05
    $8.35
    downward going graph

    3.71%

    Downside

    -0.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.00
    $11.22
    downward going graph

    28.23%

    Downside

    34.21%

    Upside

    downward going graph

BioCryst share price movements today

Previous Close
$8.80
Open
$8.34
Volume
247.8K
Market Cap
$2.3B
Day's Low - High
$8.05 - $8.35
52 Week Low - High
$6.00 - $11.22

BioCryst Historical Returns

1 Month Return
-10.52 %
3 Month Return
+ 7.51 %
1 Year Return
+ 9.93 %
3 Year Return
+ 24.36 %
5 Year Return
-42.07 %

BioCryst Stock Fundamentals & Key Indicators

Check BioCryst market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3B

EPS (TTM)

0.745

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

14.00%

PE Ratio (TTM)

0

PEG Ratio

9.3878

EBITDA

433.0M

Revenue (TTM)

940.6M

Profit Margin

-40.90%

Return On Equity TTM

-1925.37%

BioCryst vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioCryst with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioCryst image
BioCryst
BUY$2.3B-42.07%NA-40.90%NA
United Therapeutics image
United Therapeutics
BUY$21.7B141.04%16.7786.14%NA
Viatris image
Viatris
HOLD$19.4B19.57%-45.8334.83%288.98%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$40.9BNA18.8814.55%134.02%
Zoetis image
Zoetis
BUY$31.3B-64.58%12.0670.87%284.12%
See all

Stock Returns calculator for BioCryst Stock including INR - Dollar returns

The BioCryst stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

BioCryst investment value today

Current value as on today

₹1,13,113

Returns

₹13,113

(+13.11%)

Returns from BioCryst Stock

₹4,370 (+4.37%)

Dollar Impact

₹8,743 (+8.74%)

Analyst Recommendation on BioCryst Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for BioCryst. Average target price of $20.82

BioCryst Share Price Target

Get share price movements and forecasts by analysts on BioCryst.

What analysts predicted

59.85%UPSIDE

Target Price

$20.82

Current Price

$8.36

Analyzed by

9 Analysts

Target

$20.82

BioCryst target price $20.82, a slight upside of 59.85% compared to current price of $8.36. According to 9 analysts rating.

Indian Investors' Interest in BioCryst Stock

Search interest for BioCryst Stock has increased by 151% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:151% versus previous 30 day period

BioCryst Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
92
109
117
131
145
163
159
406
156
218
Gross Profit
91
107
113
125
140
160
156
396
-546
214
Operating Income
-14
8
7
-4
21
29
29
260
-701
98
EBITDA
-10
12
11
-1
24
28
32
266
-699
98
Interest Expense
24
24
24
24
23
21
19
14
19
21
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-35
-12
-13
-25
0
6
12
248
-720
79
Income Tax Expense
0
0
0
0
0
1
0
2
1
1
Net Income
-35
-12
-14
-26
0
5
12
245
-721
78
Net Profit Margin
-38.14%
-11.59%
-11.99%
-20.37%
0.02%
3.11%
8.09%
60.47%
-461.48%
35.92%

BioCryst Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
26
25
20
48
17
157
270
331
450
874
Gross Profit
23
23
20
44
16
149
264
326
438
855
Operating Income
-48
-57
-94
-99
-174
-177
-148
-103
-2
340
EBITDA
-48
-56
-90
-96
-167
-121
-143
-116
12
347
Interest Expense
6
8
9
11
14
59
99
108
98
78
Depreciation
-
0
0
0
0
0
1
1
1
1
Income Before Tax
-55
-65
-101
-108
-182
-181
-244
-226
-86
267
Income Tax Expense
6
7
2
11
13
2
2
0
1
3
Net Income
-55
-65
-101
-108
-182
-184
-247
-226
-88
263
Net Profit Margin
-209.25%
-261.18%
-490.25%
-222.99%
-1026.35%
-117.11%
-91.24%
-68.36%
-19.72%
30.16%

BioCryst Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-14
-26
0
5
12
362
-721
78
Operating Cash Flow
-1
8
-5
-27
41
41
276
-62
104
Investing Cash Flow
-2
8
17
27
29
13
-83
-268
-110
Financing Cash Flow
-1
1
-4
0
-73
-58
-202
412
-11
Change in Cash
-5
18
7
0
-16
-3
-83
82
-16

BioCryst Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-65
-101
-108
-182
-184
-247
-226
-88
263
Operating Cash Flow
-41
-92
-89
-137
-142
-161
-95
-52
329
Investing Cash Flow
-66
4
77
-6
15
-128
-131
52
-13
Financing Cash Flow
135
62
99
302
359
88
32
-5
-332
Change in Cash
28
-25
87
158
233
-201
-193
-6
-103

Mutual Funds that own BioCryst Stock

Check out the Mutual Funds with significant holdings in BioCryst.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
5.953207%
15212536
TIAA-CREF Funds
1.630085%
4165441
VANGUARD HORIZON FUNDS
1.173832%
2999553
Fidelity Salem Street Trust
0.960087%
2453361
Fidelity Concord Street Trust
0.931635%
2380656
See all

Global Institutional Holdings in BioCryst

Funds
Holdings
Vanguard
6.98%
Peter Kolchinsky
6.19%
James E. Flynn
5.91%
iShares
4.73%
SPDR
4.36%
See all

Insights on BioCryst

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -721.81M → 78.39M (in $), with an average increase of 1020.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 156.41M → 218.25M (in $), with an average increase of 28.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 61.1% return, outperforming this stock by 51.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 63.2% return, outperforming this stock by 38.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BCRX stock has moved down by -12.7%

About BioCryst

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in Phase 1; Navenibart, a monoclonal antibody plasma kallikrein inhibitor for HAE which is in Phase 3; BCX17725, an investigational protein therapeutic KLK5 inhibitor for the treatment of netherton syndrome that is in phase 1 clinical trial; STAR-0310, a monoclonal antibody OX40 antagonist for the treatment of atopic dermatitis which is in Phase 1a trial. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
OrganisationBioCryst
Headquarters4505 Emperor Boulevard, Durham, NC, United States, 27703
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Charles K. Gayer
E-voting on sharesClick here to vote

Key Management of BioCryst

Name

Title

Dr. David W. Jenkins M.A., Ph.D.

Chief Scientific Officer

Ms. Stephanie Angelini

Chief People Officer & Chief Communications Officer

Mr. Charles K. Gayer

CEO, President & Director

Ms. Alane P. Barnes

Senior VP, Chief Legal Officer & Corporate Secretary

Mr. John Ruesch

Chief Technical Operations Officer

Nick Wilder

Manager of Investor Relations

Dr. William P. Sheridan MBBS

Chief Development Officer

Dr. Yarlagadda S. Babu Ph.D.

Chief Discovery Officer

Ms. Jinky Ang Rosselli

Chief Data Innovation Officer

Mr. Babar Ghias

CFO & Head of Corporate Development

FAQs

What is BioCryst share price today?

BioCryst share price today is $8.36 as on . BioCryst share today touched a day high of $8.35 and a low of $8.05.

What is the 52 week high and 52 week low for BioCryst share?

BioCryst share touched a 52 week high of $11.22 on and a 52 week low of $6.00 on . BioCryst stock price today i.e. is trending at $8.36,which is 25.49% down from its 52 week high and 39.33% up from its 52 week low.

What is BioCryst's market capitalisation today?

BioCryst market capitalisation is $0.00T as on .

How to invest in BioCryst Stock (BCRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioCryst on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioCryst Shares that will get you 0.1794 shares as per BioCryst share price of $8.36 per share as on September 10, 2026 at 7:05 pm IST.

What is the minimum amount required to buy BioCryst Stock (BCRX) from India?

Indian investors can start investing in BioCryst (BCRX) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in BioCryst stock (as per the Rupee-Dollar exchange rate as on ). Based on BioCryst share’s latest price of $8.36 as on September 10, 2026 at 7:05 pm IST, you will get 1.1962 shares of BioCryst. Learn more about fractional shares .

What are the returns that BioCryst has given to Indian investors in the last 5 years?

BioCryst stock has given -42.07% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?